Can a Genomic Test Better Detect Aggressive Prostate Cancer?

Scientists develop cheap and quick spit test for prostate cancer

“Our study shows that the theory does work in practice – we can identify men at risk of aggressive cancers who need further tests, and spare the ...

Genetically adjusted PSA levels for prostate cancer screening - Nature

Compared to a prostate cancer PGS alone (AUC = 0.712), including genetically adjusted PSA improved detection of aggressive disease (AUC = 0.786, ...

Study : Genes linked to aggressive prostate cancer

A recent study found more genes to add to prostate cancer gene panel tests, some linked to cancers that are aggressive and more likely to ...

How Will New Imaging Techniques and Genomic Tests Help In ...

These tests and techniques can help patients make more informed decisions regarding their prostate cancer diagnosis, treatments and management ...

Genetic test predicts men's risk of developing prostate cancer

However, PSA testing is a poor screening tool because it can also produce false positive results and encourages over-detection of non-aggressive ...

Prostate Cancer – Advanced: Symptoms, Diagnosis & Treatment

As a health care tool, gene testing results can help determine whether a certain treatment may be helpful. ... aggressive prostate cancer. To learn more ...

Prostate Cancer Gene Test After Diagnosis - AARP

Newer genomic tests analyze genes from a biopsied tumor to provide additional information about how aggressive the cancer could become.

Genomic Health, Inc.'s Genetic Test Helps Identify Aggressive ...

“The results of our study showed that the individual biological information from the Oncotype DX prostate cancer test tripled the number of ...

A New Genetic Test Can Spot Aggressive Prostate Cancer - Time

In a report published in the New England Journal of Medicine, scientists say that a panel of 20 genes can distinguish the more common localized ...

Prostate Cancer Genetic Testing Lagging Despite Benefits

Patients who have mutations in genes involved in DNA repair — especially homologous recombination repair (HRR) genes such as BRCA2 — are more ...

Recent Studies Find Oncotype DX® Can Reliably Predict Risk of ...

Based on findings from three separate studies, it appears that the 17-gene Oncotype DX® Genomic Prostate Score (GPS) can help predict disease aggressiveness in ...

Prostate Cancer - Localized | Conditions - UCSF Health

A prostate MRI is more commonly used in this situation than before a first biopsy, as are the other blood and urine tests described above, and a new test called ...

Prostate cancer in your genes: what can genetic testing tell us

Many conditions now use genetic testing to match patients to the best possible treatment. Recent research has shown that this type of ...

Molecular and Genomic Testing - Prostate Cancer - Urology Austin

This risk assessment tool can help predict how aggressive the tumor may be or become in the future. This information guides the physician and patient with ...

The Decipher Prostate Genomic Classifier - Urology Times

The Decipher classifier assesses 22 features associated with prostate cancer aggressiveness. In this project, we sought to understand the ...

Doctors Debate: Should Genomic Classifiers Be Used in Prostate ...

The role of genomic classifiers as an aid in precision medicine for prostate cancer is a controversial topic.

Genomic Test Could Help Predict Aggressive Disease - Newswise

The research team found the data supported the clinical utility of the Decipher Biopsy test, according to findings published in Prostate Cancer ...

Genetic Tests | Shipley Prostate Cancer Research Center

PCA3 is a genetic test that may help detect the presence of prostate cancer. ... More Sources You Can Trust · Glossary · News. Boston University School of ...

Where to access genetic testing for prostate cancer risk

If you would like to learn more ask your GP to refer you to the local NHS genetics clinic. You will usually be sent a family history questionnaire for ...

Gene Expression Profiling and Protein Biomarkers for Prostate Cancer

The FDA has approved two tests for evaluation of gene expression profiles of prostate cancer as of April 2, 2019.